Longterm Dpp4inhibitor Use Not Tied To Fracture Risk In T2dm | Latest News RSS feed

Longterm Dpp4inhibitor Use Not Tied To Fracture Risk In T2dm - Latest News

Long-term DPP4-inhibitor use not tied to fracture risk in T2DM

(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), long-term use of dipeptidyl peptidase-4 inhibitors (DPP4-Is) is not associated with fracture risk, according to a study published online ... read more

The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?

59 It is not yet understood whether TAK-875 will lead to long-term ... use of a DPP-4 inhibitor and TAK-875 would be intriguing because it would be completely orally administered and could potentially ... read more

Merck (MRK) Will Present JANUVIA, Diabetes Pipeline, Other Data at 76th Scientific Sessions of the ADA

JANUVIA has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk ... Use caution in a patient with a history ... read more

Looking for another news?

Bolstering your armamentarium with SGLT2 inhibitors

Secondary Logo Account Saved Searches Recent Searches Register Activate Subscription Login Subscribe ... You currently have no recent searches read more

Eli Lilly & Co. (LLY) John C. Lechleiter on Q2 2016 Results - Earnings Call Transcript

At ACR, along with Incyte, we presented data for baricitinib in rheumatoid arthritis from the Phase III long-term extension ... that Trajenta, a DPP-4 inhibitor, reduced blood sugar in adults with typ... read more

Incretins & Type 2 Diabetes

Ms. D is 55 years old and has a five-year history of T2DM ... and the risk of edema: a meta-analysis. Diabetes Res Clin Pract. 2007;76(2):279-289. 7. Loke YK, Singh S, Furberg CD. Long-term use of thi... read more

Short-term PPIs tied to higher hip fracture risk in Alzheimer's

(HealthDay)—Short-term proton pump inhibitor use, but not long-term or cumulative use, is associated with an increased risk of hip fracture among Alzheimer's patients, according to a study published o... read more

Approaches to male hypogonadism in primary care

1 Despite many providers feeling less than confident in how to approach this issue, the rate of testosterone use in men over ... guideline does not recommended systematic screening in men with increas... read more

Use of Canagliflozin in Combination With and Compared to Incretin-Based Therapies in Type 2 Diabetes

In clinical and real-world studies, canagliflozin, an SGLT2 inhibitor, has demonstrated superior A1C lowering compared to the DPP-4 inhibitor ... may use this article as long as the work is properly c... read more

FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us